IL261537A - Ercc1 and other markers for stratification of non-small cell lung cancer patients - Google Patents

Ercc1 and other markers for stratification of non-small cell lung cancer patients

Info

Publication number
IL261537A
IL261537A IL261537A IL26153718A IL261537A IL 261537 A IL261537 A IL 261537A IL 261537 A IL261537 A IL 261537A IL 26153718 A IL26153718 A IL 26153718A IL 261537 A IL261537 A IL 261537A
Authority
IL
Israel
Prior art keywords
ercc1
markers
detection
lung cancer
small cell
Prior art date
Application number
IL261537A
Other languages
English (en)
Hebrew (he)
Inventor
Yau Christina
Cecchi Fabiola
Hembrough Todd
Original Assignee
Nantomics Llc
Yau Christina
Cecchi Fabiola
Hembrough Todd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nantomics Llc, Yau Christina, Cecchi Fabiola, Hembrough Todd filed Critical Nantomics Llc
Publication of IL261537A publication Critical patent/IL261537A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5752—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the lungs
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
IL261537A 2016-03-21 2018-09-02 Ercc1 and other markers for stratification of non-small cell lung cancer patients IL261537A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662311368P 2016-03-21 2016-03-21
US201662337209P 2016-05-16 2016-05-16
PCT/US2017/023080 WO2017165240A1 (en) 2016-03-21 2017-03-17 Ercc1 and other markers for stratification of non-small cell lung cancer patients

Publications (1)

Publication Number Publication Date
IL261537A true IL261537A (en) 2018-10-31

Family

ID=59900771

Family Applications (1)

Application Number Title Priority Date Filing Date
IL261537A IL261537A (en) 2016-03-21 2018-09-02 Ercc1 and other markers for stratification of non-small cell lung cancer patients

Country Status (7)

Country Link
EP (1) EP3433622A4 (de)
JP (1) JP2019513982A (de)
CN (1) CN109844539A (de)
AU (1) AU2017236791B2 (de)
CA (1) CA3016340A1 (de)
IL (1) IL261537A (de)
WO (1) WO2017165240A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2684606C1 (ru) * 2017-11-29 2019-04-10 Федеральное государственное бюджетное образовательное учреждение высшего образования "Сибирский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО СибГМУ Минздрава России) Способ комбинированного лечения немелкоклеточного рака легкого
CN113970638B (zh) 2021-10-24 2023-02-03 清华大学 确定胃癌极早期发生风险及评估胃癌前病变进展风险的分子标志及其在诊断试剂盒中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6518416B1 (en) * 2000-12-01 2003-02-11 Response Genetics, Inc. Method of determining a chemotherapeutic regimen based on ERCC1 expression
EP1835285A1 (de) * 2006-03-14 2007-09-19 Institut Gustave Roussy ERCC1-Expression bei der Prognose der Reaktion auf eine Krebs-Chemotherapie
WO2011109806A2 (en) * 2010-03-05 2011-09-09 On-Q-ity Biomarkers for the identification, monitoring, and treatment of non-small cell lung cancer (nsclc)
US20120289592A1 (en) * 2011-05-13 2012-11-15 University Of Southern California Ercc1 gene expression level is associated with clinical outcomes in esophageal cancer patients
GB201316024D0 (en) * 2013-09-09 2013-10-23 Almac Diagnostics Ltd Molecular diagnostic test for lung cancer

Also Published As

Publication number Publication date
AU2017236791B2 (en) 2020-07-02
EP3433622A4 (de) 2019-11-13
WO2017165240A1 (en) 2017-09-28
AU2017236791A1 (en) 2018-09-13
EP3433622A1 (de) 2019-01-30
CA3016340A1 (en) 2017-09-28
JP2019513982A (ja) 2019-05-30
CN109844539A (zh) 2019-06-04

Similar Documents

Publication Publication Date Title
IL267300A (en) Epigenetic markers and methods and measures related to them for the detection and management of ovarian cancer
EP3452620C0 (de) Zellfreier nachweis von methylierter tumor-dna
EP3589371A4 (de) Methylierungsmarker zur diagnose von leberzellkarzinom und lungenkrebs
DK3142751T3 (da) Anti-B7-H1- og anti-CTLA-4-antistoffer til behandling af ikke-småcellet lungecancer
EP3481954A4 (de) Methylierungsmarker für lungenkrebs und verwendungen davon
PL3357000T3 (pl) Systemy i metody wykrywania raka
EP3405109A4 (de) Niederfrequente elektromagnetische verfolgung
EP3333192A4 (de) Antikörper gegen glypican-3 und dessen anwendung
HRP20190338T1 (hr) Metoda otkrivanja raka korištenjem čula mirisa nematode
IL253160B (en) Cancer markers and methods of use thereof
DK3356558T3 (da) Sirs patogenbiomarkører og anvendelser deraf
IL290358A (en) Preparations and methods for detecting host cell proteins
EP3525582A4 (de) Arthropodenerkennung
IL254412B (en) Prostate antigen standards and uses thereof
IL281676B (en) Depth sensing systems and methods
GB2571026B (en) Detection of PH
LT3268493T (lt) Viso kraujo mrnr žymenys, skirti prostatos vėžio prognozavimui, ir jo nustatymo būdai
PL3397967T3 (pl) Kompozycje i sposoby do wykrywania i leczenia raka przełyku
IL269315A (en) Detection, quantification and/or isolation of circulating tumor cells based on the expression of cd321 marker
EP3541933A4 (de) Tumorepithelzellkulturen
EP3372686A4 (de) Biomarker für den nachweis von lungenadenokarzinom und verwendung davon
IL249741B (en) Identification of cancer stem cells markers and use of same for diagnosis and treatment
DK3405801T3 (da) Elektromagnetisk interferensindikator og tilhørende fremgangsmåde
EP3552007A4 (de) Gasdetektionstechnik
EP3798315A4 (de) Tumormarker, methylierungsdetektionsreagens, kit und verwendung davon